The BRCA-DIRECT Team is based from the Institute of Cancer Research in Sutton, forming part of the Translational Genetics Team. We are a group funded by Cancer Research UK, and are working in collaboration with SHORE-C in Sussex, The Royal Marsden Hospital in London, Manchester University NHS Foundation Trust and Manchester University to deliver this innovative new study.

​

Our lab, the NHS North Thames Genomic Laboratory Hub NIHR Biomedical Research Centre for Molecular Pathology, is based at The Royal Marsden Hospital in Sutton. The lab is an NeQAS-approved, ISO 15189 accredited medical diagnostic molecular genetics laboratory. Sample handling, sequencing, and reporting is performed to NHS diagnostic standard.

​

Below is a list of our key study investigators - if you would like to contact us about the study, please visit our Contact page for details.